Clinical Trials

The CTC conducts investigator-initiated collaborative clinical trials research across a diverse therapeutic areas, including cancer, cardiovascular disease, neonatal health and diabetes.

We have participated in over 100 investigator-initiated, cooperative-group clinical trials, and coordinated some of the largest randomised trials initiated by Australian investigators (LIPID and FIELD studies, each with over 9000 patients). Over 65 000 patients have been randomised to these trials.

The resources of multiple collaborative clinical groups have been consolidated through the CTC, ensuring a critical mass in specialised areas of expertise. This has helped our clinical trials program to grow in breadth and depth, particularly in oncology.

All trials undertaken through the CTC are conducted strictly according to guidelines for clinical trials research and conduct, and are audited by regulatory authorities, sponsors and the CTC itself.

Our capacity to conduct high-quality trials continues to grow through expansion in our infrastructure and strengthening and streamlining of operational processes.

Contact: Dr Wendy Hague, Clinical Trial Program Director